Vijay Rajasekhar is a Stanford trained MD, MBA. He has been involved in 2 FDA approvals and 2 healthcare IPOs in the last decade. Prior to founding DailyDoctor, he was the third employee of Myovant Sciences, the biggest biotech IPO of 2016, where he was a lead physician of the HERO study, a global phase 3 clinical trial of relugolix for prostate cancer that met its primary endpoint. In the past, he helped design Intersect ENT's Propel Mini for sinusitis (FDA approved 2012, IPO 2014). As a Stanford Biodesign Fellow, his team spun out CALA Health for essential tremor (FDA approved 2018). Vijay is an inventor on over a dozen patents, and is an alumnus of the Stanford Biodesign & Mayfield Fellowships. In addition to his medical background and MBA, he also completed an MS, Mechanical Engineering from Stanford, and has a background in design from time at LUNAR Design. He has helped develop technologies for emergency medicine, heart failure, essential tremor, sinusitis, and COPD.

Marlon Castillo has an MBA from Harvard Business School and a BA from Yale University. He leads the technological development and engineering of DailyDoctor. Prior to DailyDoctor, he founded a digital health company that provided remote treatment to people with diabetes. Before his career in healthcare technology, Marlon worked in the energy industry as an investor and commodities trader, during which he was among the first traders in the North American carbon markets. In business school, while an intern at NADEX, Marlon created and launched the first binary options for hurricanes, which were featured on CNBC and the Financial Times. At Yale, his thesis advisor was Nobel Prize-winning economist Robert Shiller, with whom he helped structure home equity protection derivatives as well as helped edit his book, The New Financial Order.